HFSA 2010 Comprehensive Heart Failure Practice Guideline.

Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline.

Heart failure (HF) is a syndrome characterized by high mortality, frequent hospitalization, reduced quality of life, and a complex therapeutic regimen. Knowledge about HF is accumulating so rapidly that individual clinicians may be unable to readily and adequately synthesize new information into effective strategies of care for patients with this syndrome. Trial data, though valuable, often do ...

2017 ACC/AHA/HFSA/ISHLT/ACP Advanced Training Statement on Advanced Heart Failure and Transplant Cardiology (Revision of the ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac Transplant): A Report of the ACC Competency Management Committee.

Genetic Evaluation of Cardiomyopathy - a Heart Failure Society of America Practice Guideline.

This guideline describes the approach and expertise needed for the genetic evaluation of cardiomyopathy. First published in 2009 by the Heart Failure Society of America (HFSA), this guidance has now been updated in collaboration with the American College of Medical Genetics and Genomics (ACMG). The writing group, composed of cardiologists and genetics professionals with expertise in adult and p...

Cardiology (TSOC) for the Diagnosis and Treatment of Heart Failure

Heart failure is the major terminal pathway for most cardiovascular disease. Initial heart failure guidelines were published by American College of Cardiology (ACC) and American Heart Association (AHA) in 1995, and revised guidelines followed in 2001. Subsequently, there were another two update guidelines for diagnosis and management of heart failure published by ACC/AHA in 2005 and 2009 respec...

Development and implementation of a comprehensive heart failure practice guideline.

Clinical decisions must be made. Correct course of action may not be readily apparent. Multiple non-pharmacologic, pharmacologic, and device therapies are available. Reasonably valid methods exist to address knowledge base and evaluate medical evidence. Data beyond randomized clinical trials exist that enhance medical decision making. Uncertainties remain concerning approaches to treatment afte...